Cardiff Oncology, Inc. Quarterly Common Stock, Shares, Issued from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Cardiff Oncology, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2011 to Q3 2024.
  • Cardiff Oncology, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 48.7M shares, a 9.07% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 48.7M +4.05M +9.07% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 45.6M +925K +2.07% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 44.7M +33K +0.07% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 44.7M 0 0% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 44.7M +1.34M +3.1% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 44.7M +1.37M +3.17% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 44.7M +1.37M +3.17% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 44.7M +2.71M +6.47% Dec 31, 2022 10-K 2024-02-29
Q3 2022 43.3M +3.78M +9.57% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 43.3M +3.75M +9.49% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 43.3M +5.75M +15.3% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 42M +5.18M +14.1% Dec 31, 2021 10-K 2023-03-02
Q3 2021 39.6M +13.3M +50.5% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 39.6M +18.2M +85.5% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 37.6M +26.5M +241% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 36.8M +28.2M +328% Dec 31, 2020 10-K 2022-02-24
Q3 2020 26.3M +19.8M +308% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 21.3M +15.9M +292% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 11M +6.49M +143% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 8.59M +4.76M +124% Dec 31, 2019 10-K 2021-02-25
Q3 2019 6.44M -16.5M -72% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 5.44M -11.9M -68.6% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 4.53M -54.3M -92.3% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 3.83M +3.1M +423% Dec 31, 2018 10-K 2020-02-27
Q3 2018 23M -15.1M -39.8% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 17.3M -13.8M -44.3% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 58.8M +27.9M +90% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 733K -30M -97.6% Dec 31, 2017 10-K 2019-03-06
Q3 2017 38.1M +7.51M +24.5% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 31.1M +660K +2.17% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 31M +1.19M +3.98% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 30.7M +959K +3.23% Dec 31, 2016 10-K 2018-02-26
Q3 2016 30.6M +877K +2.95% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 30.4M +5.54M +22.3% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 29.8M +5.48M +22.5% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 29.7M +10.8M +57.2% Dec 31, 2015 10-K 2017-03-15
Q3 2015 29.7M +10.8M +57.2% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 24.9M +5.97M +31.6% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 24.3M +5.4M +28.6% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 18.9M +13K +0.07% Dec 31, 2014 10-K 2016-03-10
Q3 2014 18.9M +10.8K +0.06% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 18.9M +3.17M +20.2% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 18.9M +3.39M +21.8% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 18.9M +3.42M +22.1% Dec 31, 2013 10-K 2015-03-12
Q3 2013 18.9M +4.71M +33.2% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 15.7M +1.55M +11% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 15.5M -51.6M -76.9% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 15.5M +4.74M +44.2% Dec 31, 2012 10-K 2014-03-17
Q3 2012 14.2M Sep 30, 2012 10-Q 2012-11-14
Q2 2012 14.2M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 67.1M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 10.7M Dec 31, 2011 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.